Tag: BDA

Bod Australia ASX BDA Project Twenty21 MediCabilis medicinal cannabis

Bod Australia issues first MediCabilis scripts under Europe’s largest medicinal cannabis project

Cannabis-focused healthcare company Bod Australia (ASX: BDA) has issued the first prescriptions for its MediCabilis product to UK patients participating in Europe’s largest medicinal cannabis registry...
Bod Australia Health & Happiness ASX BDA CBD CBII MediCabilis

Bod Australia receives record order for cannabinoid and hemp products

It’s been a busy week for Bod Australia (ASX: BDA) with the company following up its first UK MediCabilis prescriptions with news it had received a record $1.43 million purchase order from Health and ...
Bod Australia ASX BDA medicinal cannabis prescriptions MediCabilis

Bod Australia reveals ‘significant’ growth in medicinal cannabis prescriptions, more to come

Bod Australia (ASX: BDA) revealed this morning it has experienced “significant growth” in prescriptions for its medicinal cannabis product, with this growth expected to expand further once numerous ap...
Bod Australia ASX BDA NewH2 Health & Happiness cannabis hemp CBD

Bod Australia receives major capital boost via Health & Happiness Group’s innovation arm

Cannabis-focused healthcare company Bod Australia (ASX: BDA) has struck an exclusive agreement with investment fund NewH2 owned by Hong Kong-listed Health & Happiness Group (H&H). Under the...
Bod Australia ASX BDA PTSD cannabis CAC MediCabilis

Bod Australia’s cannabis oil to be used in landmark PTSD trial

Cannabis-focused healthcare company Bod Australia (ASX: BDA) has announced it will supply its pharmaceutical-grade cannabis extract MediCabilis for a landmark 12-month trial related to post traumatic ...
Bod Australia ASX BDA medicinal cannabis product clinical trial Phase 1

Clinical trial highlights tolerability of Bod Australia’s medicinal cannabis product

A phase one clinical trial of a sublingual cannabis wafer developed by Bod Australia (ASX: BDA) has highlighted the tolerability and superiority of the product and deemed it safe for human consumption...
Bod Australia ASX BDA MediCabilis record sales revenue December 2018 quarter

Bod Australia posts record quarterly revenue thanks to new products, distribution deals

Skincare and health products developer Bod Australia (ASX: BDA) has posted a record revenue of $1.22 million for the last quarter of 2018, underpinned by an expansion of its product range, new distrib...
Bod Australia ASX BDA medicinal cannabis wafer export licence

Bod Australia gets green light to export growing medicinal cannabis product range

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has received the green light to export its patented sublingual form of medicinal cannabis after gaining an export listing on the Austra...
Chemist Warehouse Bod Australia ASX BDA MediCabilis medicinal cannabis

Chemist Warehouse adds Bod Australia’s cannabis oil MediCabilis to its shelves

Australia’s adoption of medicinal cannabis has taken another step forward after Bod Australia (ASX: BDA) announced it has begun dispensing MediCabilis, its proprietary cannabis oil, via Chemist Wareho...
Cannabis Access Clinics Australia medical research price analysis

Cannabis Access Clinics looks to aid Australian patient access to medical cannabis

The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments, with illnesses such as epilepsy, multiple sclerosis (MS) and post-traumatic stress disorder (PTSD) a...
Bod Australia ASX BDA CBD trial cannabidiol ECs315 cannabis extract clinical trial

Bod Australia hits major milestone in cannabis wafer trial

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has achieved what it calls a “world-first” in the clinical trial of its proprietary phytocomplex cannabis extract ECs315, showing that ...
Bod Australia ASX BDA phase 1 clinical trial phytocomplex cannabis extract

Bod Australia kicks off phase 1 clinical trial for phytocomplex cannabis extract

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has stormed into a phase 1 clinical trial to test the safety, tolerability and pharmacokinetics of Bod’s proprietary phytocomplex canna...
Bod Australia ASX BDA Swisse director George Livery

Bod Australia recruits Swisse director alongside growing medical cannabis trend

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has appointed a new executive chairman to spearhead its multifaceted growth spurt in both natural medicines, but also, medical cannabis...
Bod Australia ASX BDA cannabis clinical trial approval

Bod Australia receives early green light to commence cannabis clinical trial

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has surprised the market by announcing that it has secured ethics approval in a record time of six weeks from the Human Research Ethics...
Bod Australia ASX BDA MediCabilis medicinal cannabis oil

Bod Australia sets the stage for marketing medical cannabis oil in Australia

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added yet another string to its commercial bow, by completing its first order for medicinal cannabis oil from Swiss company Linnea ...
Bod Australia ASX BDA Australian Pharmaceuticals Industries medicinal cannabis

Bod Australia obtains improved place in shop window via Australian Pharmaceuticals Industries

One of Australia’s emergent developer and distributors of cosmetics and natural medicines, Bod Australia (ASX: BDA) has secured potentially better marketability and market exposure, courtesy of a deal...
Bod Australia ASX BDA import medicinal cannabis oil

Bod Australia gains approval to commence importing medicinal cannabis oil

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added another piece to its puzzle towards commencing production of medicinal cannabis-based products in Australia. According to ...
Bod Australia ASX BDA In2Pharma Flexofytol turmeric curcumin

Bod Australia upscales natural medicines range in tandem with growing demand

Cosmetics-maker Bod Australia (ASX: BDA) has decided to upscale its sales and distribution efforts courtesy of a timely agreement with In2Pharma, a leading pharma sales broker capable of expanding Bod...
Bod Australia ASX BDA hemp manuka honey

Bod to develop hemp-based manuka honey for global markets with Manuka Pharma

Bod Australia (ASX: BDA) will develop a hemp-based, high methylglyoxal manuka honey line to distribute to global markets after pinning down a heads of agreement with New Zealand-based Manuka Pharma. ...
Bod Australia ASX BDA iX Biopharma WaferiX trial medicinal cannabis

Bod partners with iX Biopharma to incorporate medicinal cannabis in WaferiX for trials

Bod Australia (ASX: BDA) has agreed to supply its medicinal cannabis extracts to speciality pharmaceutical company iX Biopharma (SGX: 42C) for use in clinical trials. Bod’s cannabis oils and raw ma...
Bod Australia BDA ASX cannabis-based cosmetics

Bod Australia kicks off cannabis-based cosmetic development, anticipates 2018 market release

Bod Australia (ASX: BDA) and Linnea SA have kicked off exploratory work into developing cannabis-based formulas for a new cosmetics range, which Bod anticipates releasing to the market during 2018. ...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS